ArticleBJUI compass2026
Impact of ureteric stent diameter on stent-related symptoms and early outcomes after kidney transplantation: A randomised controlled trial.
Article in BJUI compass, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to evaluate the impact of ureteric stent diameter on stent-related symptoms and early urological complications in kidney transplant recipients. Patients and Methods: A single-centre randomised controlled trial that enrolled 70 kidney transplant recipients to receive either a 4.8 Fr or 6 Fr ureteric stent allocated at a 1:1 ratio was conducted. Stent-related symptoms and patient-reported outcomes were assessed using the Ureteral Stent Symptom Questionnaire (USSQ) and a visual analogue scale (VAS) for pain. Early postoperative complications-including urinary leakage, ureteric obstruction and urinary tract infection (UTI)-were recorded. Results: The 4.8 Fr stents were associated with significantly fewer stent-related symptoms and lower USSQ scores than 6 Fr stents (47.0 ± 4.5 vs. 53.9 ± 4.2; Conclusion: The 4.8 Fr ureteric stents reduce stent-related symptoms and postoperative pain while demonstrating a similar early safety profile to 6 Fr stents. These findings support the use of smaller-calibre stents to improve postoperative comfort following kidney transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.